-
公开(公告)号:US20220135658A1
公开(公告)日:2022-05-05
申请号:US17434249
申请日:2020-03-13
Applicant: MORPHOSYS AG
Inventor: Julia NEUGEBAUER , Barbara BACHLER-KONETZKI , Tanja HERRMANN , Winfried ELLIS
IPC: C07K16/18
Abstract: The present invention provides novel antibodies or antibody fragments specifically binding to human C5aR. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment of inflammatory or autoimmune diseases or cancer.